Czechia vs Southern Asia: Proportion of the target population who received the final dose of
Czechia
75.0%
in 2024
Southern Asia
8.0%
in 2024
Czechia rank
32nd
Southern Asia rank
32nd
Proportion of the target population who received the final dose of over time
- Czechia
- Southern Asia
How they compare
Czechia currently reports 75.0% against 8.0% in Southern Asia, a difference of 67.0%.
That makes Czechia's figure about 9.4 times Southern Asia's.
Across all 13 years both countries report, Czechia has been ahead every year.
Czechia ranks 32nd and Southern Asia ranks 32nd of 107 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Southern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 67.4% | 0.2% | 67.1% | Czechia |
| 2020s | 71.4% | 2.4% | 69.0% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Czechia or Southern Asia?
- Czechia, at 75.0% against 8.0% in Southern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Czechia and Southern Asia?
- 67.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Southern Asia?
- 13 years are reported by both, from 2012 to 2024.
- How do Czechia and Southern Asia rank globally for proportion of the target population who received the final dose of?
- Czechia ranks 32nd and Southern Asia ranks 32nd of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.